Gout and Uric Acid After 40: A Short Guide to the <6.0 mg/dL Target
A short guide to gout and uric acid after 40, covering the serum urate target, HLA-B*58:01 in Thai adults, acute-pain medication, and weak diet evidence

Gout after age forty is not only occasional joint pain. This evidence bundle states that in men aged 40 and older, high uric acid is the main physiological driver of gout, and major guidelines recommend treating to a target rather than waiting for pain and reacting only then.
This short version summarizes what to ask your doctor about: the serum urate target, allopurinol safety in Thai adults, weak evidence for diet claims, and choosing acute-flare medication according to individual risk.
Three-Line Summary
- Clinical guidelines recommend keeping serum urate below 6.0 mg/dL to help prevent joint damage and systemic complications.
- In Thai patients with gout, HLA-B*58:01 testing before allopurinol is cost-effective and reduces the risk of life-threatening SCARs.
- Diet or supplements, including purine restriction, vitamin C, and cherry juice, still have weak and inconclusive evidence compared with standard treatment.
Uric Acid Target and Why Chronic Gout Should Not Be Ignored
The 2020 American College of Rheumatology guideline recommends a treat-to-target strategy, keeping serum urate below 6.0 mg/dL. The goal is to help prevent joint damage and systemic complications.
Long-term cohort data also indicate that achieving and maintaining target serum urate is associated with lower risks of chronic kidney disease progression and major adverse cardiovascular events in patients with gout.
⚠️ Caveat: “associated with” is not a promise that one number will definitely prevent kidney or heart disease for every person, and this article does not provide instructions for self-adjusting medication.
Thai Adults and HLA-B*58:01
A 2025 economic evaluation in Thailand reported that HLA-B*58:01 testing before allopurinol in Thai patients with gout is a cost-effective preventive strategy and reduces allopurinol-induced severe cutaneous adverse reactions, or SCARs, which can be life-threatening.
If your doctor is considering allopurinol, asking about HLA-B*58:01 is a safety discussion, not excessive alarm.
Diet and Supplements: Do Not Overstate the Evidence
A 2025 systematic review of randomized controlled trials found that evidence for diet or supplements on gout-related outcomes remains weak and inconclusive. The examples named in the evidence bundle are purine restriction, vitamin C, and cherry juice.
The important message is: diet can still matter, but these diet or supplement approaches should not be described as replacements for standard treatment or as guaranteed ways to lower uric acid and prevent gout flares.
| Topic | What the evidence bundle says | Confidence for readers |
|---|---|---|
| Serum urate | Keep below 6.0 mg/dL under a treat-to-target guideline | Strong within guideline context |
| HLA-B*58:01 | Testing before allopurinol in Thai adults is cost-effective and reduces SCARs | Strong for the Thai context |
| Diet and supplements | Purine restriction, vitamin C, and cherry juice have weak evidence | Limited |
| Kidneys and heart | Reaching serum urate target is associated with lower CKD progression and MACE | Strong for association, not a personal guarantee |
During a Flare and With Other Conditions: Let a Doctor Help Choose
For acute gout attacks, the evidence bundle states that low-dose colchicine, NSAIDs, and oral corticosteroids provide comparable pain reduction, but selection should depend on each patient’s cardiovascular and renal risk profile.
If you have kidney disease, cardiovascular disease, take several medications, or have had problems with pain medicines before, consult a doctor or pharmacist first. Do not choose medication on your own from a list in an article.
Start Tomorrow, One Step First
You do not need to change your whole life tomorrow. Just carry one question into your next visit with a doctor or pharmacist, such as “Should my serum urate stay below 6.0 mg/dL, and am I at that target now?”
If you are about to start allopurinol, ask about HLA-B*58:01. If you are in pain, ask which pain medicine fits your kidneys, your heart, and the medications you already take. Small steps like these help you look after yourself and the people you love more safely, without having to guess.
This summary is for understanding, not medical advice. Testing, interpretation, and medication decisions should be made with the doctor or qualified professional who cares for you. The full version contains the complete rationale and research.



Summary complete
This was the key-points summary
Want to understand why, and the research behind it? Read the full version.
Read the full reasoning and researchRead next
More in this category

Long COVID: A Short Guide to Fatigue, Brain Fog, Palpitations, and Pacing
A short guide to Long COVID, or PASC, covering what the research finds, common symptoms such as fatigue, brain fog, and palpitations on standing, why pushing through exercise may make people with post-exertional malaise (PEM) worse, the pacing approach studied to manage symptoms, and the warning signs that need a doctor, all as health education rather than a diagnosis, with no promise of a cure.
Read article
Oral Health and Chronic Disease: How Gum Disease Links to the Heart and Diabetes
A short guide to oral health and chronic disease, covering what periodontitis is, how it is linked to the heart and diabetes through inflammation, why the heart link is observational and not proof of cause, why there is no evidence that gum treatment prevents heart attack or stroke, the stronger two-way link with diabetes, who should be careful, and how to start looking after your oral health.
Read article
Adult Vaccination: A Short Guide to Why It Still Matters and How to Talk to Your Doctor
A short guide to adult vaccination, covering why immunity fades with age, which vaccine categories tend to be relevant for adults, why vaccines protect both you and the people around you, and how to start a conversation with your own doctor or pharmacist to find what fits you.
Read articleVerifiable
References for this article
- 1 2020 American College of Rheumatology Guideline for the Management of Gout - FitzGerald et al., Arthritis Care & Research (2020, PMID 32391934) pubmed.ncbi.nlm.nih.gov
- 2 An Updated Economic Evaluation of HLA-B*58:01 Genotype Testing in Gouty Patients for Preventing Severe Allopurinol Hypersensitivity in Thailand - Dilokthornsakul et al., ACR Open Rheumatology (2025, PMID 40829930) pubmed.ncbi.nlm.nih.gov
- 3 Effect of Diet and Dietary Supplements on Gout-Related Outcomes: A Systematic Review of Randomised Controlled Trials - Pardali et al., Mediterranean Journal of Rheumatology (2025, PMID 41647273) pubmed.ncbi.nlm.nih.gov
- 4 Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease - Wang et al., JAMA Internal Medicine (2025, PMID 39585678) pubmed.ncbi.nlm.nih.gov
- 5 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout - Rahman et al., International Journal of Rheumatic Diseases (2021, PMID 34931463) pubmed.ncbi.nlm.nih.gov
Reviewed by Health Coach: A888